Cancer-Specific Integrin Imaging With 68 Ga-Trivehexin : A Potential Imaging for Accurate Staging of Thyroid Malignancy.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 39499025.
- Also identified by DOI 10.1097/RLU.0000000000005557.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
68 Ga-Trivehexin is a novel radiotracer binding to "cancer-specific integrin αvβ6." 68 Ga-Trivehexin has high specificity for tumor cells and, thus, has the potential to replace 18 F-FDG PET/CT due to its limited specificity in the head and neck cancer. Here, we present one case of papillary thyroid carcinoma, where 68 Ga-Trivehexin PET CT demonstrated accurate staging compared with 18 F-FDG PET/CT.
Medical subject headings
- Neoplasm Staging
- Positron Emission Tomography Computed Tomography
- Thyroid Neoplasms